Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Identifying which cash back cards are worth it can enhance your financial strategy. Explore the top options for maximizing rewards.
25,607 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
MercadoLibre's fourth-quarter results showed strong revenue growth, but a notable drop in profitability. This article...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
A 65-year-old couple with $2.7 million in retirement assets faces a $48,000 annual drain from a Sonoma vineyard. The ...
The latest trustees report signals coming pressures on Social Security. This guide breaks down what that means for ev...
When a headline pairs two combat icons, it’s more than hype—it’s a blueprint for money decisions. This piece turns th...
Super Micro Computer's stock has swung wildly in the AI era. This guide explains what the current valuation means, ho...
When a film icon dives into music, money isn’t the only thing at stake. This article breaks down the personal-finance...
Space investing has moved from hype to real dollars. This deep dive compares Intuitive Machines and MDA Space to help...
Lineage (Line) 2026 earnings analysis dives into Q1 results, margin trends, and management’s guidance. Learn what the...
As investors scan headlines in June, Comcast's bold $8 billion UK theme park plan stands out. This article explains w...
When markets wobble, resilient essentials stocks shine. Meet three proven picks that have stood the test of time: Pro...